Practical implication
Organizations must update their adverse event reporting processes to align with the clarified classification of borderline products effective immediately.
The MHRA has refined criteria for distinguishing between medical devices and medicinal products, particularly affecting the classification of borderline products like alcohol-only pre-injection swabs and wipes. This clarification impacts the applicable safety reporting frameworks (MDR vs. GVP) for adverse event reporting.
What changed: Refined classification criteria for determining whether a product falls under Medical Device Regulations or Human Medicines Regulations, particularly affecting alcohol-only pre-injection swabs and wipes.
Why it matters: Accurate classification ensures compliance with the correct reporting frameworks, thereby enhancing safety monitoring and regulatory adherence.
Practical implication: Organizations must update their adverse event reporting processes to align with the clarified classification of borderline products effective immediately.
View original source
Published from the Firecrawl policy change extraction pipeline.
